Gilead Sciences
Director, US Market Access - New Products & Launch Planning
- Location
- (Multi-state)Hybrid
- Posted
- Posted Nov 19 (employer shows the date only)
- Source
- Workday (employer's applicant tracking system)
- Category
- Operations/Patient Services
- Industry
- Pharma/Biotech
Application: Workday — account required, long form — you fill it in on the employer's site.
UNTIL never charges to apply and never asks for payment or personal info on behalf of employers.
Apply kitYour saved details, ready to copy
From the employer's posting
We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.
Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next.
We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfill their aspirations. Join Kite and help create more tomorrows.
Job Description
The Director, New Products & Launch Planning reports to the Sr Director, Head of US Payer, Value, and Access Strategy and is a portfolio-level individual contributor responsible for representing US Market Access in new product planning, pipeline strategy, and launch readiness for Kite’s future cell therapy assets. This role is accountable for ensuring US access considerations are incorporated early and effectively into global planning, evidence generation, launch strategy, commercialization assumptions, and cross-functional decision making.
This role will serve as the primary US Market Access lead for pre-launch and launch planning activities for longer-range horizon products, partnering closely with Global Market Access, Global Commercial, US Brand teams, HEOR, Medical Affairs, Regulatory, Legal, Compliance, Pricing & Contracting, Trade, Provider Access Marketing, Payer & Value Marketing, Field Market Access teams, Patient Services, and Portfolio & Strategic Planning. The Director will help ensure each pipeline asset enters the US market with a clear, integrated, and access-ready strategy that reflects payer, provider, employer, reimbursement, guideline, evidence, and stakeholder realities.
This is a hybrid position with three days per week in one of our four offices: Thousand Oaks, CA; El Segundo, CA; Foster City, CA; or Parsippany, NJ.
Key Responsibilities
New Product Planning and Pipeline Strategy
- Serve as the US Market Access lead for pipeline assets and new product planning activities
- Represent US Market Access in global and cross-functional planning forums related to pipeline assets, new indications, lifecycle opportunities, and future launch priorities
- Develop integrated US access strategies for pipeline assets, including payer, provider, reimbursement, evidence, employer, policy, and market readiness considerations
- Identify potential access risks and opportunities early in development and recommend mitigation strategies
- Ensure US Market Access perspectives are incorporated into global development plans, commercialization assumptions, evidence plans, value strategy, product positioning, and launch planning
Launch Access Strategy and Readiness
- Lead Market Access launch planning for future assets and indications, ensuring cross-functional alignment across all US Market Access functions
- Develop and maintain launch access workplans, milestones, readiness scorecards, and executive updates
- Partner with Provider Access Marketing and Payer & Value Marketing to identify required launch resources, customer tools, value materials, and stakeholder education needs
- Partner with Pricing & Contracting and Trade to ensure launch access planning reflects expected pricing, contracting, distribution, reimbursement, and operational requirements
- Ensure launch readiness plans address the first 30, 60, 90, and 180 days post-approval, including payer coverage, provider readiness, field enablement, customer resources, and access operations
Global and Cross-functional Interface
- Serve as a primary US Market Access interface to Global Market Access and applicable global asset teams
- Provide US access input into global launch planning, market research, evidence generation, payer research, value proposition development, and commercialization strategy
- Partner with Global and US teams to ensure launch assumptions are realistic and grounded in US payer, provider, employer, reimbursement, and access dynamics
- Influence cross-functional teams to prioritize access-related activities that are critical to launch success
- Ensure US Market Access leadership is informed of key pipeline decisions, launch tradeoffs, risks, and resource needs
Evidence, Value, and Guideline Planning
- Partner with HEOR, Medical Affairs, Regulatory, Global Market Access, and Payer & Value Marketing to identify payer and provider evidence needs for pipeline assets
- Identify evidence gaps that could limit coverage, reimbursement, guideline inclusion, provider adoption, or stakeholder confidence at launch
- Support development of payer evidence requirements, value narrative considerations, and launch-related evidence translation priorities
…
Similar live roles
- Director, Process Lead - Integrated Planning and Capacity Management
AstraZeneca · Posted today - Director, Process Lead - Materials Planning and Supply
AstraZeneca · Posted today - Senior Director, Planning Center of Excellence (CoE) Lead
AstraZeneca · Posted today - SMA Family Access Manager - Midwest Region
Biogen · Posted today - Plasma Center Medical Support Specialist EMT-B
Takeda · Posted today - Plasma Center Technician
Takeda · Posted today